CNBX Pharmaceuticals CNBX
OTC CNBX
$0.00 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

CNBX Pharmaceuticals Inc. (CNBX) Return on Sales (2016 - 2024)

CNBX Pharmaceuticals' (CNBX) quarterly Return on Sales came in at 0.11% in Q4 2024, down 9.0% YoY from 0.13% in Q4 2023, and down 144.38% on a QoQ basis from 0.05% in Q3 2024.

CNBX Pharmaceuticals Inc. (CNBX) Return on Sales (2016 - 2024) Analysis & Trends

CNBX Pharmaceuticals (CNBX) has 9 years of Return on Sales data on file, last reported at 0.11% in Q4 2024.

  • Quarterly Return on Sales fell 9.0% year-over-year to 0.11% in Q4 2024, while the trailing twelve-month figure through Nov 2024 was 0.11% (down 10.0% YoY) and the FY2024 annual result came in at 0.31%, down 21.0% from the prior year.
  • Return on Sales declined to 0.11% in Q4 2024, from 0.05% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.01% in Q2 2023 to a low of 31.72% in Q2 2021.
  • A 5-year average of 5.69% and a median of 0.38% in 2023 frame the typical range for Return on Sales.
  • Annual changes were most pronounced in 2021 — Return on Sales slumped 2806 bps — and 2023, when it jumped 90 bps.
  • Tracing CNBX's Return on Sales over 5 years: stood at 12.04% in 2020, then slumped by 164 bps to 31.72% in 2021, then surged by 97 bps to 0.92% in 2022, then surged by 98 bps to 0.02% in 2023, then plunged by 456 bps to 0.11% in 2024.
  • The last three Return on Sales figures came in at 0.11% (Q4 2024), 0.05% (Q3 2024), and 0.03% (Q2 2024), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
Nov 30, 2024 -0.11%
Aug 31, 2024 -0.05%
May 31, 2024 -0.03%
Feb 29, 2024 -0.05%
Nov 30, 2023 -0.02%
Aug 31, 2023 -0.02%
May 31, 2023 -0.01%
Feb 28, 2023 -0.59%
Nov 30, 2022 -0.92%
Aug 31, 2022 -0.16%
May 31, 2021 -31.72%
Feb 28, 2021 -15.56%
Nov 30, 2020 -12.04%
Aug 31, 2020 -19.42%
May 31, 2020 -3.66%
Feb 29, 2020 -6.61%
Nov 30, 2019 -4.65%
Aug 31, 2019 -14.45%
May 31, 2019 -3.61%
Feb 28, 2019 -3.86%